Ausgabe 2/2014
Inhalt (25 Artikel)
Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis
Francisco E. Vera-Badillo, Marc Napoleone, Alberto Ocana, Arnoud J. Templeton, Bostjan Seruga, Mustafa Al-Mubarak, Hashem AlHashem, Ian F. Tannock, Eitan Amir
Pneumonitis and pulmonary fibrosis associated with breast cancer treatments
Claudia Omarini, Eirini Thanopoulou, Stephen R. D. Johnston
A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression
Jangsoon Lee, Chandra Bartholomeusz, Oula Mansour, Juliane Humphries, Gabriel N. Hortobagyi, Peter Ordentlich, Naoto T. Ueno
Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth
Stefania Catalano, Cinzia Giordano, Salvatore Panza, Francesca Chemi, Daniela Bonofiglio, Marilena Lanzino, Pietro Rizza, Francesco Romeo, Suzanne A. W. Fuqua, Marcello Maggiolini, Sebastiano Andò, Ines Barone
Recurrent read-through fusion transcripts in breast cancer
Katherine E. Varley, Jason Gertz, Brian S. Roberts, Nicholas S. Davis, Kevin M. Bowling, Marie K. Kirby, Amy S. Nesmith, Patsy G. Oliver, William E. Grizzle, Andres Forero, Donald J. Buchsbaum, Albert F. LoBuglio, Richard M. Myers
Monitoring patient-centered outcomes through the progression of breast reconstruction: a multicentered prospective longitudinal evaluation
Li-Fen Chao, Ketan M. Patel, Shin-Cheh Chen, Hung-Bun Lam, Chia-Yu Lin, Hsueh-Erh Liu, Ming-Huei Cheng
Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers
Tarek Abdel-Fatah, Arvind Arora, Devika Agarwal, Paul Moseley, Christina Perry, Nicola Thompson, Andrew R. Green, Emad Rakha, Stephen Chan, Graham Ball, Ian O. Ellis, Srinivasan Madhusudan
Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer
Kristi McIntyre, Joyce O’Shaughnessy, Lee Schwartzberg, Stefan Glück, Erhan Berrak, James X. Song, David Cox, Linda T. Vahdat
Erratum to: Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer
Kristi McIntyre, Joyce O’Shaughnessy, Lee Schwartzberg, Stefan Glück, Erhan Berrak, James X. Song, David Cox, Linda T. Vahdat
Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting
Laura Evangelista, Anna Rita Cervino, Riccardo Sanco, Michele Bignotto, Tania Saibene, Silvia Michieletto, Cristina Ghiotto, Fernando Bozza, Marta Paiusco, Giorgio Saladini
Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04)
Jin Hee Kim, Doo Ho Choi, Won Park, Seung Do Ahn, Su Ssan Kim, Sung Whan Ha, Kyubo Kim, Yong Bae Kim, Ji Woon Yea, Min Kyu Kang, Kyung Hwan Shin, Dong Won Kim, Ji Hae Lee, Chang-Ok Suh
Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast
C. Fraga-Guedes, H. Gobbi, M. G. Mastropasqua, R. M. Rocha, E. Botteri, A. Toesca, G. Viale
Differential impact of body mass index on absolute and percent breast density: implications regarding their use as breast cancer risk biomarkers
Susann E. Schetter, Terryl J. Hartman, Jason Liao, John P. Richie, Bogdan Prokopczyk, Cindy DuBrock, Carina Signori, Christopher Hamilton, Laurence M. Demers, Karam El-Bayoumy, Andrea Manni
The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy
Amany R. Keruakous, Betro T. Sadek, Mina N. Shenouda, Andrzej Niemierko, Rita F. Abi Raad, Michelle Specht, Barbara L. Smith, Alphonse G. Taghian
Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?
Eva Maria Fallenberg, Clarisse Dromain, Felix Diekmann, Diane M. Renz, Heba Amer, Barbara Ingold-Heppner, Avidan U. Neumann, Klaus J. Winzer, Ulrich Bick, Bernd Hamm, Florian Engelken
Dietary fat intake in relation to lethal breast cancer in two large prospective cohort studies
Caroline E. Boeke, A. Heather Eliassen, Wendy Y. Chen, Eunyoung Cho, Michelle D. Holmes, Bernard Rosner, Walter C. Willett, Rulla M. Tamimi
Pregnancy during breast cancer: does a mother’s parity status modify an offspring’s mortality risk?
Leonardo Simonella, Helena M. Verkooijen, Gustaf Edgren, Jenny Liu, Miao Hui, Agus Salim, Kamila Czene, Mikael Hartman
Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study
Jennifer H. Jordan, Soe Soe Thwin, Timothy L. Lash, Diana S. M. Buist, Terry S. Field, Reina Haque, Pamala A. Pawloski, Hans V. Petersen, Marianne N. Prout, Virginia P. Quinn, Marianne Ulcickas Yood, Rebecca A. Silliman, Ann M. Geiger
Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival
Shi-Yi Wang, Jessica B. Long, Arti Hurria, Cynthia Owusu, Richard M. Steingart, Cary P. Gross, Jersey Chen
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
Jacek Gronwald, Andre Robidoux, Charmaine Kim-Sing, Nadine Tung, Henry T. Lynch, William D. Foulkes, Siranoush Manoukian, Peter Ainsworth, Susan L. Neuhausen, Rochelle Demsky, Andrea Eisen, Christian F. Singer, Howard Saal, Leigha Senter, Charis Eng, Jeffrey Weitzel, Pal Moller, Dawna M. Gilchrist, Olufunmilayo Olopade, Ophira Ginsburg, Ping Sun, Tomasz Huzarski, Jan Lubinski, Steven A. Narod
Differential impact of non-insulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus on breast reconstruction outcomes
Charles Qin, Elbert Vaca, Francis Lovecchio, Jon P. Ver Halen, Nora M. Hansen, John Y. S. Kim
Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women
Yong Cui, Sandra L. Deming-Halverson, Martha J. Shrubsole, Alicia Beeghly-Fadiel, Hui Cai, Alecia M. Fair, Xiao-Ou Shu, Wei Zheng
Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer
K. Bell, N. Hodgson, M. Levine, B. Sadikovic, K. Zbuk
Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case series
Vincent Sibaud, Rachel E. Niec, Katja Schindler, Klaus J. Busam, Henri Roché, Shanu Modi, Jean Pierre Delord, Mario E. Lacouture
3D volumetric analysis for planning breast reconstructive surgery
Michael P. Chae, David J. Hunter-Smith, Robert T. Spychal, Warren Matthew Rozen